Maxcyte, Inc.
MXCTNasdaqCIK 1287098IndustrialsFiscal year ends Dec 31
Reports and events: 87 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-11-0822:12 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001558370-23-018314 |
| 2023-11-0821:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-018276 |
| 2023-10-0420:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-016235 |
| 2023-08-0920:55 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001558370-23-014306 |
| 2023-08-0920:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-014270 |
| 2023-06-2313:27 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-23-074068 |
| 2023-05-1021:03 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001558370-23-009167 |
| 2023-05-1020:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-009107 |
| 2023-04-2820:22 ET | DEF 14A | Proxy statementPeriod 2023-06-22 | 0001104659-23-053015 |
| 2023-03-2813:40 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-037467 |
| 2023-03-1521:01 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001558370-23-003911 |
| 2023-03-1520:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-003872 |
| 2023-03-0622:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-002942 |
| 2022-12-0113:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-22-123467 |
| 2022-11-0922:01 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001558370-22-017204 |
| 2022-11-0921:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-017166 |
| 2022-08-1021:03 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001558370-22-013091 |
| 2022-08-1020:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-013073 |
| 2022-06-3020:44 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-22-076335 |
| 2022-05-2620:35 ET | DEF 14A | Proxy statementPeriod 2022-06-29 | 0001140361-22-020805 |
| 2022-05-0921:00 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001558370-22-007869 |
| 2022-05-0920:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-007826 |
| 2022-04-2920:27 ET | 10-K/A | Annual report, amendedPeriod 2021-12-31 | 0001104659-22-053626 |
| 2022-04-1220:26 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-22-045082 |
| 2022-03-2221:16 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001558370-22-004081 |
| 2022-03-2220:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-004073 |
| 2022-01-2422:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-006977 |
| 2021-11-1021:51 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001558370-21-015534 |
| 2021-11-1021:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-136950 |
| 2021-11-0220:30 ET | 8-K | 5.07 Shareholder vote results | 0001104659-21-133041 |
| 2021-10-0112:36 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-21-121662 |
| 2021-10-0111:00 ET | DEF 14A | Proxy statementPeriod 2021-10-29 | 0001104659-21-121580 |
| 2021-09-1720:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-116945 |
| 2021-09-1320:34 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001558370-21-012432 |
| 2021-08-0420:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-21-100067 |
| 2021-07-2610:03 ET | S-1/A | Registration statement, amended | 0001104659-21-095556 |
| 2021-07-0920:48 ET | S-1 | Registration statement | 0001104659-21-090682 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. Listed shows no prices and gives no investment advice.